Evidence-based deprescribing algorithms help clinicians decide when and how to reduce medications safely and how to monitor effect. Each algorithm provides a one-page summary of its related evidence-based deprescribing guideline published by, or in collaboration with the Bruyère Deprescribing Guideline Research Team.
Deprescribing Information Pamphlets
Information pamphlets help patients, their families, and caregivers to better understand the rationale for deprescribing particular medications and give approaches for deprescribing and monitoring for patients and their health care providers to discuss. Some pamphlets are connected to the Bruyere Deprescribing Guidelines Research Team’s evidence-based guidelines and others are produced by the University of Montreal’s EMPOWER research team.
“More than 90% of patients are willing to stop a medication if their doctor says it is possible”Reeve E, Wolff JL, Skehan M, Bayliss EA, Hilmer SN, Boyd CM (2018) “Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States.” JAMA Internal Medicine; Published online 15 Oct 2018
Deprescribing Patient Decision Aids
The Bruyère Deprescribing Guidelines Research Team’s graduate student, Wade Thompson has developed and tested a consult patient decision aid aimed at helping to decide whether to continue taking a proton pump inhibitor, use a lower dose, or stop and use on-demand.
Case Reports and Testimonials
A variety of deprescribing case reports and testimonials are available, to help you learn more about deprescribing, whether it is the right choice for patients, when to have the conversation with health care providers, and how to reduce medication safely.
Much has been published about polypharmacy and deprescribing. Here you will find some key publications that we consider useful. If you have suggestions for other useful references, please Tweet them!
“The guideline is great because it reinforces the way I practice. I feel better about what I’m doing and why I’m doing it. It is helpful to know that my colleagues agree and that there’s written literature to support me.”Pharmacist participating in the deprescribing guidelines implementation pilot